DICE Therapeutics

Technology Company

Worked at DICE Therapeutics

JS

Jim Scopa

Director, Chair of Audit Committee at Neuron23 Inc.

ND

Nathan Davis

Analyst at RA Capital Management

SC

Shaan C. Gandhi

VP at Pfizer

DICE Therapeutics Investors

JS

Jake Simson

Partner at RA Capital Management

All information is sourced from public domain and might be inaccurate.